FONT-SIZE Plus   Neg

Correction: Bunge Q4 Profit Down - Quick Facts

correction: corrects last year's figure for net income to Bunge common shareholders in the first para.

Bunge Ltd. (BG) posted a decline in its fourth-quarter net income attributable to the company to $254 million from $301 million in the prior-year quarter, with net income to Bunge common shareholders dropping to $245 million from $292 million in the previous year.

Quarterly earnings per share were $1.65, a decrease from $1.95 in the earlier year quarter. Earnings per share, excluding certain gains & charges, amounted to $1.99 a year earlier. On average, 12 analysts polled by Thomson Reuters expected earnings per share of $1.57 for the quarter. Analysts' estimates typically exclude one-time items.

Net sales for the three-month period were $16.44 billion, higher than last year's $12.73 billion, while eight analysts estimated revenues of $13.73 billion for the quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Consumer goods giant Procter & Gamble Co. on Tuesday reported a 4 percent increase in profit for the first quarter from last year on a slight decline in sales. However, both revenue and core earnings per share for the quarter beat analysts' estimates. In addition, the company affirmed its financial outlook for fiscal 2017. Merck & Co. Inc. (MRK) reported a profit for the third-quarter that increased about 20 percent, while quarterly worldwide sales grew 5 percent. The company raised its full-year 2016 outlook. Drug maker Eli Lilly and Co. reported Tuesday lower profit in its third quarter, despite higher revenues. Adjusted earnings per share and top line missed analysts' estimates. Further, for fiscal 2016, the company trimmed its forecast for reported earnings, while maintained adjusted earnings view, and raised revenue forecast.
comments powered by Disqus
Follow RTT